HBW Insight is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


Cosmetic User Fees, FDA Warnings, California: Top “Rose Sheet” Topics Of 2012

This article was originally published in The Rose Sheet

Executive Summary

“The Rose Sheet” offers an overview of the year in cosmetics, analyzing 2012’s biggest news and the publication’s most-read stories. Highlights include a proposal in Obama’s 2013 budget request to institute cosmetics user fees, the rash of late-year warning letters and regulatory developments in California.


Related Content

Stakeholders Hopeful New Congress Addresses Cosmetics Legislation
Banana Boat Sunscreen Recall Could Raise Questions On Spray Standards
Rash Of FDA Warning Letters Raises Questions For Cosmetics Industry
FDA Serves Up More Warnings: Avon Cited For Touting Druglike Benefits
California Green Chemistry Reg Revision Narrows “Concern” List
EC’s SCCS Concurs With CIR On Methylene Glycol In Hair Straighteners
In Brief
Heavy Metals, Estrogenics Among Research Priorities For FDA's Cosmetics Office
House Hearing Probes FDA’s Cosmetics Role
FDA Proposes $19 Mil. In Cosmetics User Fees To Support Enhanced Oversight


Related Companies




Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts